Follow
Sergiusz Nawrocki
Sergiusz Nawrocki
profesor medycyny Uniwersytet Warmińsko-Mazurski
No verified email
Title
Cited by
Cited by
Year
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
C Butts, MA Socinski, PL Mitchell, N Thatcher, L Havel, M Krzakowski, ...
The lancet oncology 15 (1), 59-68, 2014
5522014
Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours)
B Kos-Kudła, J Blicharz-Dorniak, J Strzelczyk, A Bałdys-Waligórska, ...
Endokrynologia Polska 68 (2), 79-110, 2017
1192017
Expression of interleukin‐6, interleukin‐6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma
A Karczewska, S Nawrocki, D Brȩborowicz, V Filas, A Mackiewicz
Cancer: Interdisciplinary International Journal of the American Cancer …, 2000
772000
START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.
CA Butts, MA Socinski, P Mitchell, N Thatcher, L Havel, MJ Krzakowski, ...
Journal of Clinical Oncology 31 (15_suppl), 7500-7500, 2013
662013
Genetically modified tumour vaccines–where we are today
S Nawrocki, A Mackiewicz
Cancer treatment reviews 25 (1), 29-46, 1999
661999
Genetically modified tumour vaccines (GMTV) in melanoma clinical trials
S Nawrocki, P Murawa, J Malicki, M Kapcinska, K Gryska, D Izycki, ...
Immunology Letters 74 (1), 81-86, 2000
372000
Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized …
S Nawrocki, M Krzakowski, E Wasilewska-Tesluk, D Kowalski, ...
Journal of Thoracic Oncology 5 (8), 1255-1262, 2010
352010
Nowotwory nabłonkowe narządów głowy i szyi
A Kawecki, S Nawrocki, W Golusiński, U Grzesiakowska, J Jassem, ...
Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach …, 2013
322013
Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer
S Nawrocki, PJ Wysocki, A Mackiewicz
Expert opinion on biological therapy 1 (2), 193-204, 2001
302001
Consensus statement on a screening programme for the detection of early lung cancer in Poland
W Rzyman, J Didkowska, R Dziedzic, T Grodzki, T Orłowski, E Szurowska, ...
Advances in Respiratory Medicine 86 (1), 53-74, 2018
262018
SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: toxicity and quality of life assessment
M Rucinska, A Kieszkowska-Grudny, S Nawrocki
Strahlentherapie Und Onkologie 192, 449, 2016
232016
Complementary and alternative medicine use in hospitalized cancer patients—study from Silesia, Poland
K Kasprzycka, M Kurzawa, M Kucharz, M Godawska, M Oleksa, ...
International Journal of Environmental Research and Public Health 19 (3), 1600, 2022
222022
Numerical simulations for tumor and cellular immune system interactions in lung cancer treatment
M Kolev, S Nawrocki, B Zubik-Kowal
Communications in nonlinear science and numerical simulation 18 (6), 1473-1480, 2013
222013
Clinical study and numerical simulation of brain cancer dynamics under radiotherapy
S Nawrocki, B Zubik-Kowal
Communications in Nonlinear Science and Numerical Simulation 22 (1-3), 564-573, 2015
202015
Students’ knowledge about cervical cancer prevention in Poland
K Osowiecka, S Yahuza, M Szwiec, A Gwara, K Kasprzycka, M Godawska, ...
Medicina 57 (10), 1045, 2021
192021
The Polish Cancer Anemia Survey (POLCAS): a retrospective multicenter study of 999 cases
MZ Wojtukiewicz, E Sierko, M Rybaltowski, E Filipczyk-Cisarz, ...
International journal of hematology 89, 276-284, 2009
192009
Ocena jakości życia i strategii radzenia sobie z chorobą w grupie chorych poddanych zabiegowi endoprotezoplastyki stawu biodrowego
A Kieszkowska-Grudny, J Maleszewska, A Siwy-Hudowska, S Nawrocki
Gerontologia Polska 2, 62-9, 2014
152014
COVID-19 pandemic: impact on cancer patients
M Rucinska, S Nawrocki
International Journal of Environmental Research and Public Health 19 (19), 12470, 2022
142022
How long are cancer patients waiting for oncological therapy in Poland?
K Osowiecka, M Rucinska, JJ Nowakowski, S Nawrocki
International Journal of Environmental Research and Public Health 15 (4), 577, 2018
142018
From microarrays to new therapeutic approaches in bladder cancer
S Nawrocki, T Skacel, T Brodowicz
Pharmacogenomics 4 (2), 179-189, 2003
132003
The system can't perform the operation now. Try again later.
Articles 1–20